SNHG12 is a potential biomarker in various cancer types, including gastric cancer, non-small cell lung cancer, triple-negative breast cancer, hepatocellular carcinoma, etc. Therefore, targeting SNHG12 could lead to advances in the diagnoses, prognosis, and/or treatment of these cancers [37]. Here, SNHG12 is linked to cancer.